BIOMAT Database Logo BIOMAT Database Logo

[Vasodilation therapy of cardiac insufficiency in ischemic heart disease]. 1979

V Stanĕk, and I Málek, and J Pavlovic, and J Widimský

UI MeSH Term Description Entries
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Cardiac insufficiency in ischemic heart disease].
July 1976, Kardiologiia,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Nitrate therapy for ischemic heart disease and cardiac insufficiency].
November 1989, Deutsche medizinische Wochenschrift (1946),
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Treatment of cardiac insufficiency in ischemic heart disease].
November 1990, Archives des maladies du coeur et des vaisseaux,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Treatment of acute cardiac insufficiency in ischemic heart disease].
January 1981, Revista espanola de cardiologia,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Cardiac insufficiency due to ischemic heart disease - hypertension, ischemic heart disease and myocardial infarct].
August 1975, Nihon rinsho. Japanese journal of clinical medicine,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Diagnosis of cardiac insufficiency in patients with ischemic heart disease].
November 1985, Vrachebnoe delo,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[A fourth tone and latent cardiac insufficiency in ischemic heart disease].
April 1982, Minerva medica,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Use of mindronate in cardiac insufficiency in patients with ischemic heart disease].
January 1990, Klinicheskaia meditsina,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Isolated ultrafiltration in the treatment of cardiac insufficiency in ischemic heart disease].
January 1983, Terapevticheskii arkhiv,
V Stanĕk, and I Málek, and J Pavlovic, and J Widimský
[Vasodilation treatment of heart insufficiency].
May 1978, Ugeskrift for laeger,
Copied contents to your clipboard!